Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01052480
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
Conditions: Influenza A;   Influenza B
Interventions: Biological: Anti-Influenza Immune Plasma;   Behavioral: Standard Care

Study has passed its completion date and status has not been verified in more than two years.